Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, December 2, 2010 AI, SVNT, EPAY, BMRN, WBD, AVNW Are Seasonally Ripe To Go Up In the Next Five Weeks
December 2, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ARLINGTON ASSET INVESTMENT-A (NYSE:AI), SAVIENT PHARMACEUTICALS INC (NASDAQ:SVNT), BOTTOMLINE TECHNOLOGIES INC (NASDAQ:EPAY), BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), WIMM-BILL-DANN FOODS-ADR (NYSE:WBD), AVIAT NETWORKS INC (NASDAQ:AVNW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date
AI ARLINGTON ASSET INVESTMENT-A 17.880 % 83.33% (10 of 12) Friday, January 14th 2011
SVNT SAVIENT PHARMACEUTICALS INC 17.320 % 80.95% (17 of 21) Friday, January 14th 2011
EPAY BOTTOMLINE TECHNOLOGIES INC 17.140 % 90.91% (10 of 11) Friday, January 14th 2011
BMRN BIOMARIN PHARMACEUTICAL INC 16.450 % 100.00% (11 of 11) Friday, January 14th 2011
WBD WIMM-BILL-DANN FOODS-ADR 16.300 % 87.50% (7 of 8) Friday, January 7th 2011
AVNW AVIAT NETWORKS INC 15.980 % 78.26% (18 of 23) Friday, January 14th 2011
ARLINGTON ASSET INVESTMENT-A (NYSE:AI) - Arlington Asset Investment Corp. invests in mortgage-related assets. It acquires and holds residential mortgage-backed securities, which are either issued by a U.S. government agency, or guaranteed as to principal and interest by the U.S. government agencies or the U.S. government-sponsored entities. The company also acquires and holds mortgage-backed securities issued by private organizations. In addition, it holds merchant banking opportunities, including investments in equity securities, mezzanine debt, and senior loans. The company was formerly known as Friedman, Billings, Ramsey Group, Inc. Arlington Asset Investment Corp. was founded in 1989 and is based in Arlington, Virginia.
SAVIENT PHARMACEUTICALS INC (NASDAQ:SVNT) - Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States. The KRYSTEXXA is being developed as a treatment for chronic gout in patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. It sells its products directly to drug wholesalers. The company, formerly known as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in June 2003. Savient Pharmaceuticals, Inc. was founded in 1980 and is headquartered in East Brunswick, New Jersey.
BOTTOMLINE TECHNOLOGIES INC (NASDAQ:EPAY) - Bottomline Technologies (de), Inc. markets and provides electronic payment, invoice, and document automation solutions to corporations, financial institutions, and banks worldwide. Its solutions are used to streamline, automate, and manage processes and transactions involving global payments, invoice receipt and approval, collections, cash management, document management, reporting, and document archive. The company offers payment and document automation solutions, which produce various domestic and international payment instructions along with consolidated bank reporting of cash activity, including ACH, EDI, Fedwire transfer, BACSTEL-IP and SWIFT messaging, and paper checks in various currencies. It also provides a legal spend management solution, Legal eXchange, which integrates with claims management, and time and billing systems to automate legal invoice management processes and to provide insight into companys outside legal spend. In addition, the company offers WebSeries Electronic Banking Platform that allows banks and financial institutions to deploy Internet-based cash management services for their corporate clients, as well as hosted and outsourced accounts payable automation solutions. Further, it provides professional services; consumable products for laser check printing, including magnetic ink character recognition toner and blank-paper check stock; and printers and printer-related equipment. Bottomline Technologies (de), Inc. sells and markets its products and services through its sales force, and various channel partners and reseller relationships to various industries, such as financial services, insurance, health care, technology, communications, education, media, manufacturing, and government. The company was founded in 1989 and is headquartered in Portsmouth, New Hampshire.
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) - BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises approved products and multiple investigational product candidates. The companys approved products include Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used to treat genetic disease called mucopolysaccharidosis (MPS)VI; Kuvan tablet, a proprietary synthetic oral form of 6R-BH4, a naturally occurring enzyme co-factor for phenylalanine hydroxylase indicated for patients with Phenylketonuria (PKU); Aldurazyme, which is used to treat mucopolysaccharidosis I caused by the deficiency of a lysosomal enzyme called alpha-L-iduronidase; and Firdapse, an orphan drug for the treatment of lambert eaton myasthenic syndrome. Its other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is under Phase II clinical development for the treatment of PKU; GALNS (N-acetylgalactosamine 6-sulfatase), which is under in Phase I/II clinical development for the treatment of MPS IVA; and BMN 195, a Phase I clinical development product for the treatment of duchenne muscular dystrophy. The company is also conducting preclinical development of various other enzyme product candidates for genetic and other metabolic diseases, including BMN-185, an IgA protease for IgA nephropathy; and BMN-103, a glucosidase for pompe disease. In addition, BioMarin holds rights to receive royalties related to Orapred and Orapred ODT as a result of sublicense of North American rights. The company sells its products to specialty pharmacies, hospitals acting as retailers, pharmaceutical wholesalers, and distributors in the United States, Europe, Latin America, and internationally. It has a strategic alliance with Merck Serono S.A. and collaboration with Genzyme Corporation. The company was founded in 1996 and is headquartered in Novato, California.
WIMM-BILL-DANN FOODS-ADR (NYSE:WBD) - Wimm-Bill-Dann Foods OJSC manufactures and sells dairy, beverage, and baby food products primarily in the Russian Federation. Its principal dairy products include sterilized and pasteurized milk, and butter and cream, as well as traditional sour-milk products, such as kefir, cottage cheese, soft cottage cheese, and sour cream; yogurts and dairy desserts, such as traditional and drinking yogurt, fruit-flavored milk and kefir, puddings, and flavored cottage cheese; and cheese products, including hard yellow and processed cheese. The companys beverage products primarily comprise juices and nectars produced from juice concentrates; enriched juice-based drinks; Mors, a traditional berry-juice-based drink made from natural berries; bottled natural mineral water; and drinking water. Its baby food products include liquid dairy products, and juices and water for infants under the age of three; meat, fish, poultry, fruit, vegetable, and dairy purees for children aged three and under; dry formula for feeding babies; products for pregnant women and nursing mothers; and other food products for children. The company sells its products through various sales channels, including independent distributors and wholesalers, supermarket chains, small- and medium-sized grocery stores, open air markets, pavilions, and restaurants. Wimm-Bill-Dann Foods OJSC was founded in 1992 and is based in Moscow, the Russian Federation.
AVIAT NETWORKS INC (NASDAQ:AVNW) - Aviat Networks, Inc. engages in the design, manufacture, and sale of a range of wireless networking products, solutions, and services worldwide. The company offers a product portfolio that addresses the needs of service providers and network operators addressing a range of applications, frequencies, capacities, and network topologies. Its product categories include 4G/WiMAX (fixed and mobile) broadband access, licensed and license-exempt point-to-point microwave radios, and element and network management software. The company offers broadband wireless access base stations and customer premises equipment based upon the IEEE 802.16d-2004 and 16e-2005 standards for fixed and mobile WiMAX; licensed point-to-point microwave radios that include Eclipse, a platform for nodal wireless transmission systems; TRuepoint, a platform for ultra-high capacity trunking applications; and Constellation, a family of medium-to-high-capacity point-to-point digital radios that operate in the 6, 7/8, and 10/11 GHz frequencies, which are designed for network applications and support both PDH and SONET. It also offers license-exempt wireless interconnection for wireless access, cellular backhaul, Internet service, local and wide area networking, and emergency response communications systems. In addition, the company provides NetBoss, a family of network management and service assurance solutions for managing multi-vendor, multi-technology communications networks; and ProVision, a centralized network monitoring and control system to manage wireless transmission networks. The company also offers professional services, including installation and commissioning and training. It serves mobile and fixed telephone service providers, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast system operators. Aviat Networks, Inc. is headquartered in Santa Clara, California.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
- WOPRAI
- support@woprai.com